Nancy Baron-Welch
Women's Health · Newark, DENPI 1245514140
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$569
- Astellas Pharma US Inc$457
- Evofem Biosciences, Inc.$335
- AbbVie$302
- Exeltis, USA Inc.$214
- Myovant Sciences Inc.$194
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,67895%
- Education$2005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 26 | $569 |
| Astellas Pharma US Inc | 22 | $457 |
| Evofem Biosciences, Inc. | 18 | $335 |
| AbbVie | 18 | $302 |
| Exeltis, USA Inc. | 12 | $214 |
| Myovant Sciences Inc. | 11 | $194 |
| Sumitomo Pharma America, Inc. | 10 | $189 |
| Sage Therapeutics, LLC | 10 | $181 |
| Millicent US Inc | 9 | $168 |
| Amgen | 7 | $150 |
| Coopersurgical, Inc. | 6 | $119 |
| Therapeuticsmd, Inc. | 6 | $115 |
| Daiichi Sankyo Inc. | 6 | $106 |
| Pfizer | 5 | $100 |
| Myriad Women's Health, Inc. | 1 | $98 |
| Mylan Pharmaceuticals Inc. | 5 | $86 |
| Exact Sciences | 4 | $85 |
| Organon | 3 | $81 |
| Bayer | 4 | $71 |
| Shield Therapeutics Inc | 3 | $58 |
| Davol Inc. | 1 | $43 |
| Agile Therapeutics, Inc. | 2 | $40 |
| Avion Pharmaceuticals | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Aspira Women's Health Inc | 1 | $21 |
| Scynexis, Inc. | 1 | $18 |
| Merck | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
How this compares
$3,877 in reported general payments places this provider in the 95th percentile of 29 women's health providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 23 | $1,504 |
| Alendronate Sodium | 15 | $187 |
Paid to pharmacies, not to this prescriber.
Other women's health in Newark
- Lauren RaineyNewark$916
- Jimena JolleyNewark$522
- Rachel McCabeNewark$310
- Catherine EarnestNewark$239
- Nicolette AlbertNewark$169
- Aileen McElhaneyNewark$76
- Virginia SchlittNewark$66
- Leigh FergusonNewark$62
- Sara LamonicaNewark$25
- Lisa ShallisNewark$23
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.